Virtu Financial LLC Onconova Therapeutics, Inc. Transaction History

Virtu Financial LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$0.57 - $1.0 $15,592 - $27,356	27,356 New	27,356 $12,000
Q4 2022 Feb 15, 2023	SELL	$0.63 - $0.97 $4,069 - $6,266	-6,460 Reduced 27.56%	16,982 $11,000
Q3 2022 Nov 07, 2022	BUY	$0.95 - $1.45 $22,269 - $33,990	23,442 New	23,442 $21,000
Q1 2022 May 17, 2022	SELL	$1.46 - $2.82 $17,563 - $33,924	-12,030 Closed	0 $0
Q4 2021 Feb 17, 2022	BUY	$2.49 - $3.73 $29,954 - $44,871	12,030 New	12,030 $31,000

249K

Ticker ONTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,895,600
Market Cap $12.3M
Description
Onconova Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel products to treat cancer. It has two clinical-stage programs, including narazaciclib (ON 123300), a multi-targeted kinase inhibitor that is in Phase I study for solid tumors, as well as hematological malignancies as a single agent...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.